NEW YORK , Oct. 7, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced its participation in the 2024 Maxim Healthcare Virtual Summit. Chaim Lebovits , President and CEO of BrainStorm, will join Jason McCarthy , Ph.D., Senior Managing Director and Head of Biotechnology Research at Maxim Group, for a Fireside... Read More